glycine has been researched along with Glycine Encephalopathy in 75 studies
Excerpt | Relevance | Reference |
---|---|---|
"Glycine encephalopathy (GE), also known as non-ketotic hyperglycinemia, is a life-threatening metabolic disease caused by inherited deficiency of the glycine cleavage system (GCS)." | 8.87 | Two novel laboratory tests facilitating diagnosis of glycine encephalopathy (nonketotic hyperglycinemia). ( Kure, S, 2011) |
"Glycine encephalopathy (GCE) is a rare autosomal recessive disorder caused by defects in the glycine cleavage complex." | 7.81 | Novel compound heterozygous LIAS mutations cause glycine encephalopathy. ( Matsumoto, N; Miyake, N; Nakashima, M; Ogata, K; Saitsu, H; Shiina, M; Shimada, S; Shimojima, K; Tanaka, R; Tsurusaki, Y; Yamamoto, T, 2015) |
" The patient was found to have glycine encephalopathy resulting from a previously defined mutation in the GLDC gene." | 7.80 | Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing. ( Adıyaman, G; Biberoğlu, G; Çiftci, B; Ezgu, F; Gökmenoğlu, H; Hasanoğlu, A; Kasapkara, Ç; Küçükçongar, A; Topçu, B; Tümer, L, 2014) |
"Classic neonatal-onset glycine encephalopathy (GE) is devastating and life threatening." | 7.73 | Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation. ( Flusser, H; Galil, A; Korman, SH; Kure, S; Matsubara, Y; Sato, K, 2005) |
"Glycine encephalopathy, or nonketotic hyperglycinaemia (NKH; Mckusick 238300) is a severe autosomal recessive disease due to a defect in the glycine cleavage system (GCS), which is a complex of four subunits: P-, T-, H- and L-proteins." | 7.73 | Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy. ( Bonnet, V; Cheillan, D; Conter, C; Froissart, R; Maire, I; Rolland, MO, 2006) |
"Glycine encephalopathy (GE) (non-ketotic hyperglycinemia) is an autosomal recessive neurometabolic disease caused by defective activity of the glycine cleavage system." | 7.73 | A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. ( Ben-Neriah, Z; Boneh, A; Kanno, J; Korman, SH; Kure, S; Lerer, I; Matsubara, Y; Sato, K, 2005) |
"A defect in the P-protein component of the glycine cleavage system has been the most frequent abnormality found in patients with glycine encephalopathy (NKH)." | 7.72 | Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH). ( Applegarth, DA; Coulter-Mackie, MB; Lee, G; Levy, HL; Toone, JR, 2003) |
"An asphyxiated neonate with pyridoxine-dependent seizures and associated transient nonketotic hyperglycinemia is reported." | 7.70 | Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. ( Goto, K; Inutsuka, M; Izumi, T; Maeda, T, 2000) |
"Glycine is a major neurotransmitter that activates inhibitory glycine receptors and is a co-agonist for excitatory glutamatergic N-methyl-D-aspartate (NMDA) receptors." | 5.43 | Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. ( Armbruster, A; Baris, HN; Ekhilevitch, N; Eulenburg, V; Hannappel, E; Hauf, K; Hershkovitz, D; Hershkovitz, T; Ilivitzki, A; Kurolap, A; Mahajnah, M; Mandel, H; Mory, A; Nijem, Y; Paperna, T; Sella, E; Tal, G, 2016) |
"Glycine encephalopathy, also known as nonketotic hyperglycinemia (NKH), is an inherited neurometabolic disorder with variable clinical course and severity, ranging from infantile epileptic encephalopathy to psychiatric disorders." | 4.12 | Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia. ( Cortès-Saladelafont, E; Garbade, SF; García-Cazorla, Á; García-Jiménez, MC; Guder, P; Hoffmann, GF; Honzík, T; Horvath, G; Ibáñez, S; Jeltsch, K; Juliá-Palacios, NA; Kulhánek, J; Kuseyri Hübschmann, O; Kuster, A; Olivella, M; Opladen, T; Pearson, TS; Santer, R; Zafeiriou, DI, 2022) |
"GLYT1 encephalopathy is a form of glycine encephalopathy caused by disturbance of glycine transport." | 4.02 | GLYT1 encephalopathy: Further delineation of disease phenotype and discussion of pathophysiological mechanisms. ( Casellas-Vidal, D; Diego-Álvarez, D; Espuña-Capote, N; García-González, MDM; Mademont-Soler, I; Maroto, A; Obón, M; Perapoch, J; Queralt, X; Ruiz, MD; Trujillo, A, 2021) |
"Delayed emergence from anesthesia was previously reported in a case study of a child with Glycine Encephalopathy." | 4.02 | Elevated preoptic brain activity in zebrafish glial glycine transporter mutants is linked to lethargy-like behaviors and delayed emergence from anesthesia. ( Bindernagel, R; Buglo, E; Dallman, JE; Engert, F; Kelz, MB; Meng, QC; Randlett, O; Sloan, SA; Stark, MJ; Sumathipala, SH; Syed, S; Venincasa, MJ; Yan, Q; Züchner, S, 2021) |
"Nonketotic hyperglycinemia (NKH) or glycine encephalopathy is an autosomal recessive disorder of glycine metabolism resulting in an excessive accumulation of glycine in all body tissues, including the central nervous system." | 3.91 | Nonketotic Hyperglycinemia: Two Case Reports and Review. ( Al Futaisi, A; Al Murshidi, F; Al Thihli, K; Poothrikovil, RP, 2019) |
"Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues." | 3.88 | Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level. ( Drapeau, P; Greene, NDE; Lepage, N; Leung, KY; Liao, M; Pena, IA; Riché, R; Samarut, É; Sarafoglou, K; Schimmenti, LA, 2018) |
"Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH)." | 3.83 | Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans. ( Alfadhel, M; Alfares, A; Ali, QA; Alkuraya, F; Alrifai, MT; Arold, ST; Douglas, GV; Juusola, J; Mutairi, FA; Nashabat, M; Qahtani, HA; Shaalan, HA; Wierenga, K, 2016) |
" The patient was found to have glycine encephalopathy resulting from a previously defined mutation in the GLDC gene." | 3.80 | Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing. ( Adıyaman, G; Biberoğlu, G; Çiftci, B; Ezgu, F; Gökmenoğlu, H; Hasanoğlu, A; Kasapkara, Ç; Küçükçongar, A; Topçu, B; Tümer, L, 2014) |
"Classic neonatal-onset glycine encephalopathy (GE) is devastating and life threatening." | 3.73 | Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation. ( Flusser, H; Galil, A; Korman, SH; Kure, S; Matsubara, Y; Sato, K, 2005) |
"Glycine encephalopathy (GE) (non-ketotic hyperglycinemia) is an autosomal recessive neurometabolic disease caused by defective activity of the glycine cleavage system." | 3.73 | A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. ( Ben-Neriah, Z; Boneh, A; Kanno, J; Korman, SH; Kure, S; Lerer, I; Matsubara, Y; Sato, K, 2005) |
"A defect in the P-protein component of the glycine cleavage system has been the most frequent abnormality found in patients with glycine encephalopathy (NKH)." | 3.72 | Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH). ( Applegarth, DA; Coulter-Mackie, MB; Lee, G; Levy, HL; Toone, JR, 2003) |
" NKH is classically associated with neonatal apnea, lethargy, hypotonia, and seizures, followed by severe psychomotor retardation in those who survive." | 3.72 | Natural history of nonketotic hyperglycinemia in 65 patients. ( Applegarth, D; Hamosh, A; Hoover-Fong, JE; Shah, S; Toone, J; Van Hove, JL, 2004) |
"An asphyxiated neonate with pyridoxine-dependent seizures and associated transient nonketotic hyperglycinemia is reported." | 3.70 | Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. ( Goto, K; Inutsuka, M; Izumi, T; Maeda, T, 2000) |
"Glycine has multiple neurotransmitter functions in the central nervous system (CNS)." | 2.43 | Lessons from the knocked-out glycine transporters. ( Armsen, W; Betz, H; Eulenburg, V; Gomeza, J, 2006) |
"Nonketotic hyperglycinemia is an autosomal recessive inborn error of glycine metabolism, characterized by deficient activity of the glycine cleavage enzyme system." | 1.62 | Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia. ( Bayrak, H; Ceylaner, S; Kasapkara, ÇS; Kılıç, M; Küçükcongar, A; Olgaç, A; Yıldız, Y; Yüksel, D; Zenciroğlu, A, 2021) |
"High glycine (GLY) levels have been suggested to induce neurotoxic effects in the central nervous system of patients with nonketotic hyperglycinemia (NKH)." | 1.48 | Glycine Administration Alters MAPK Signaling Pathways and Causes Neuronal Damage in Rat Brain: Putative Mechanisms Involved in the Neurological Dysfunction in Nonketotic Hyperglycinemia. ( Fernandez Cardoso, GM; Gasparotto, J; Gelain, DP; Grings, M; Leipnitz, G; Moreira, JCF; Moura, AP; Parmeggiani, B; Seminotti, B; Wajner, M, 2018) |
"This is the case for nonketotic hyperglycinemia (NKH), a Mendelian disorder causing seizures in neonates and early-infants, primarily due to mutations in the GLDC gene." | 1.46 | Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease. ( Abia, D; Arribas-Carreira, L; Bravo-Alonso, I; Couce, ML; Domingo, R; García-Cazorla, A; Morais, A; Navarrete, R; Pérez, B; Pérez-Cerdá, C; Perona, A; Ramos, MA; Rodríguez-Pombo, P; Swanson, MA; Ugarte, M; Van Hove, JLK, 2017) |
"Glycine is a major neurotransmitter that activates inhibitory glycine receptors and is a co-agonist for excitatory glutamatergic N-methyl-D-aspartate (NMDA) receptors." | 1.43 | Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. ( Armbruster, A; Baris, HN; Ekhilevitch, N; Eulenburg, V; Hannappel, E; Hauf, K; Hershkovitz, D; Hershkovitz, T; Ilivitzki, A; Kurolap, A; Mahajnah, M; Mandel, H; Mory, A; Nijem, Y; Paperna, T; Sella, E; Tal, G, 2016) |
"Nonketotic hyperglycinemia is a neurometabolic disorder characterized by intellectual disability, seizures, and spasticity." | 1.42 | Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. ( Applegarth, DA; Bjoraker, KJ; Coughlin, CR; Creadon-Swindell, G; Hennermann, JB; Mahieu, V; Matthijs, G; Scharer, GH; Spector, EB; Swanson, MA; Szerlong, HJ; Tong, S; Toone, JR; Van Hove, JL; Williams, K, 2015) |
"We report 3 cases of nonketotic hyperglycinemia, 2 typical neonatal and 1 atypical, diagnosed in Pediatric Hospital of Coimbra, Portugal, and investigated at Laboratory of Biochemical Genetics in 2004 to 2010 (incidence 1:47 455; prevalence 1:782 951)." | 1.39 | Nonketotic hyperglycinemia: a cause of encephalopathy in children. ( Diogo, L; Garcia, P; Grazina, M; Henriques, R; Robalo, C; Simões, M; Veríssimo, C, 2013) |
"Hyperglycinemia was induced in healthy vervet monkeys when treated with a single oral dose of 50 mg/kg valproate." | 1.38 | Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate. ( Bergh, JJ; Kotze, HF; Mienie, LJ; Terre'Blanche, G; Viljoen, J, 2012) |
"The diagnosis of nonketotic hyperglycinemia is traditionally based on the finding of a raised cerebrospinal fluid-to-plasma-glycine ratio." | 1.36 | Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia. ( Cheong, JL; Manley, BJ; Sokol, J, 2010) |
"Patients affected by nonketotic hyperglycinemia (NKH) usually present severe neurological symptoms and suffer from acute episodes of intractable seizures with leukoencephalopathy." | 1.35 | Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats. ( Amaral, AU; Beskow, AP; Dutra Filho, CS; Fernandes, CG; Leipnitz, G; Seminotti, B; Solano, AF; Wajner, M, 2009) |
"Nonketotic hyperglycinemia was confirmed enzymatically." | 1.34 | Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course. ( Carpenter, K; Chiong, MA; Procopis, P; Wilcken, B, 2007) |
"His glycine index was 0." | 1.34 | Neonatal nonketotic hyperglycinemia. ( Bhamkar, RP; Colaco, P, 2007) |
"The glycine index is a stable, individually specific parameter in patients with NKH." | 1.33 | Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. ( De Becker, M; Declercq, P; Hennermann, JB; Jaeken, J; Kishnani, PS; Mahieu, V; Mertens, S; Van Hove, JL; Vande Kerckhove, K, 2005) |
"Neonatal-type nonketotic hyperglycinemia treatment remains unsatisfactory, even if started early." | 1.32 | Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan. ( Chien, YH; Chou, SP; Hsu, CC; Huang, A; Hwu, WL; Lee, WT; Lu, FL, 2004) |
"Three of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration and/or sodium benzoate with or without ketamine and had transient neonatal or absent symptoms and normal developmental outcome, despite persisting biochemical evidence of nonketotic hyperglycinemia." | 1.32 | Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation. ( Boneh, A; Ergaz, Z; Gomori, JM; Gutman, A; Ichinohe, A; Kojima, K; Korman, SH; Kure, S; Sato, K, 2004) |
"Nonketotic hyperglycinemia is a life-threatening disorder in neonates characterized by a deficiency of the glycine cleavage system." | 1.31 | Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia. ( Chabrol, B; Confort-Gouny, S; Cozzone, PJ; Nicoli, F; Viola, A; Viout, P, 2002) |
"Inherited deficiency of the GCS causes nonketotic hyperglycinemia (NKH), an inborn error of glycine metabolism." | 1.31 | Structure and expression of the glycine cleavage system in rat central nervous system. ( Aoki, Y; Hisanaga, K; Kojima, K; Kondo, H; Kure, S; Matsubara, Y; Owada, Y; Sakata, Y; Sato, K; Satoh, J; Shinka, T; Suzuki, Y, 2001) |
"This leukoencephalopathy has an autosomal-recessive mode of inheritance." | 1.30 | Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. ( Gabreëls, FJ; Jaeken, J; Kure, S; van der Knaap, MS; van Raaij-Selten, B; Verhoeven, NM; Wevers, RA, 1999) |
"The diagnosis of nonketotic hyperglycinemia is considered to depend upon the presence of increased cerebrospinal fluid glycine and an increased cerebrospinal fluid to plasma glycine ratio." | 1.30 | Atypical nonketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio. ( Applegarth, DA; Jackson, AH; Kure, S; Levy, HL; Toone, JR, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (4.00) | 18.2507 |
2000's | 29 (38.67) | 29.6817 |
2010's | 30 (40.00) | 24.3611 |
2020's | 13 (17.33) | 2.80 |
Authors | Studies |
---|---|
Swanson, MA | 6 |
Miller, K | 1 |
Young, SP | 1 |
Tong, S | 2 |
Ghaloul-Gonzalez, L | 1 |
Neira-Fresneda, J | 1 |
Schlichting, L | 1 |
Peck, C | 1 |
Gabel, L | 1 |
Friederich, MW | 2 |
Van Hove, JLK | 7 |
Kuseyri Hübschmann, O | 1 |
Juliá-Palacios, NA | 1 |
Olivella, M | 1 |
Guder, P | 1 |
Zafeiriou, DI | 1 |
Horvath, G | 1 |
Kulhánek, J | 1 |
Pearson, TS | 1 |
Kuster, A | 1 |
Cortès-Saladelafont, E | 1 |
Ibáñez, S | 1 |
García-Jiménez, MC | 1 |
Honzík, T | 1 |
Santer, R | 2 |
Jeltsch, K | 1 |
Garbade, SF | 1 |
Hoffmann, GF | 1 |
Opladen, T | 1 |
García-Cazorla, Á | 2 |
Arribas-Carreira, L | 2 |
Dallabona, C | 1 |
Farris, J | 2 |
Østergaard, E | 1 |
Tsiakas, K | 1 |
Hempel, M | 1 |
Aquaviva-Bourdain, C | 1 |
Koutsoukos, S | 1 |
Stence, NV | 3 |
Magistrati, M | 1 |
Spector, EB | 2 |
Kronquist, K | 3 |
Christensen, M | 1 |
Karstensen, HG | 1 |
Feichtinger, RG | 1 |
Achleitner, MT | 1 |
Lawrence Merritt Ii, J | 1 |
Pérez, B | 2 |
Ugarte, M | 3 |
Grünewald, S | 1 |
Riela, AR | 1 |
Julve, N | 1 |
Arnoux, JB | 1 |
Haldar, K | 2 |
Donnini, C | 1 |
Lund, AM | 1 |
Mayr, JA | 1 |
Rodriguez-Pombo, P | 3 |
Shelkowitz, E | 2 |
Saneto, RP | 2 |
Al-Hertani, W | 2 |
Lubout, CMA | 2 |
Brown, MS | 2 |
Long, P | 2 |
Walleigh, D | 2 |
Nelson, JA | 2 |
Perez, FE | 2 |
Shaw, DWW | 2 |
Michl, EJ | 2 |
Poothrikovil, RP | 1 |
Al Thihli, K | 1 |
Al Futaisi, A | 1 |
Al Murshidi, F | 1 |
Nasrallah, F | 2 |
Ben Chehida, A | 1 |
Kraoua, I | 1 |
Hadj-Taieb, S | 2 |
Sanhaji, H | 2 |
Tebib, N | 2 |
Feki, M | 2 |
Kaabachi, N | 2 |
Leung, KY | 3 |
De Castro, SCP | 1 |
Santos, C | 1 |
Savery, D | 2 |
Prunty, H | 2 |
Gold-Diaz, D | 1 |
Bennett, S | 1 |
Heales, S | 2 |
Copp, AJ | 2 |
Greene, NDE | 2 |
Ichikawa, K | 1 |
Inami, Y | 1 |
Kaneko, K | 1 |
Chehida, AB | 1 |
Jelassi, A | 1 |
Ben Massoued, S | 1 |
Charfi, M | 1 |
Zidi, W | 1 |
Amri, F | 1 |
Helel, KB | 1 |
Mejaoual, H | 1 |
Seboui, H | 1 |
Mahdhaoui, N | 1 |
Gargouri, A | 1 |
Monastiri, K | 1 |
Turki, I | 1 |
Cheour, M | 1 |
Mademont-Soler, I | 1 |
Casellas-Vidal, D | 1 |
Trujillo, A | 1 |
Espuña-Capote, N | 1 |
Maroto, A | 1 |
García-González, MDM | 1 |
Ruiz, MD | 1 |
Diego-Álvarez, D | 1 |
Queralt, X | 1 |
Perapoch, J | 1 |
Obón, M | 1 |
Alam, MS | 1 |
Rajashekara, AM | 1 |
Venincasa, MJ | 1 |
Randlett, O | 1 |
Sumathipala, SH | 1 |
Bindernagel, R | 1 |
Stark, MJ | 1 |
Yan, Q | 1 |
Sloan, SA | 1 |
Buglo, E | 1 |
Meng, QC | 1 |
Engert, F | 1 |
Züchner, S | 1 |
Kelz, MB | 1 |
Syed, S | 1 |
Dallman, JE | 1 |
Bayrak, H | 1 |
Yıldız, Y | 1 |
Olgaç, A | 1 |
Kasapkara, ÇS | 1 |
Küçükcongar, A | 2 |
Zenciroğlu, A | 1 |
Yüksel, D | 1 |
Ceylaner, S | 2 |
Kılıç, M | 1 |
Majethia, P | 1 |
Somashekar, PH | 1 |
Hebbar, M | 1 |
Kadavigere, R | 1 |
Praveen, BK | 1 |
Girisha, KM | 1 |
Shukla, A | 1 |
Scalais, E | 1 |
Osterheld, E | 1 |
Weitzel, C | 1 |
De Meirleir, L | 1 |
Mataigne, F | 1 |
Martens, G | 1 |
Shaikh, TH | 1 |
Coughlin, CR | 3 |
Yu, HC | 1 |
Swanson, M | 1 |
Scharer, G | 1 |
Helbling, D | 1 |
Wendt-Andrae, J | 1 |
Garcia, SM | 1 |
Spector, E | 2 |
Creadon-Swindell, G | 3 |
Walter, M | 1 |
Christensen, E | 1 |
Sass, JO | 1 |
Lin, Y | 1 |
Zheng, Z | 1 |
Sun, W | 1 |
Fu, Q | 1 |
Sato, K | 5 |
Riché, R | 1 |
Liao, M | 1 |
Pena, IA | 1 |
Lepage, N | 1 |
Sarafoglou, K | 1 |
Schimmenti, LA | 1 |
Drapeau, P | 1 |
Samarut, É | 1 |
Magwebu, ZE | 1 |
Mazinu, M | 1 |
Abdul-Rasool, S | 1 |
Chauke, CG | 1 |
Knaepper-Martin, S | 1 |
Boix, H | 1 |
Ezgu, F | 1 |
Çiftci, B | 1 |
Topçu, B | 1 |
Adıyaman, G | 1 |
Gökmenoğlu, H | 1 |
Kasapkara, Ç | 1 |
Biberoğlu, G | 1 |
Tümer, L | 1 |
Hasanoğlu, A | 1 |
Yilmaz, BS | 1 |
Kor, D | 1 |
Mert, GG | 1 |
Incecik, F | 1 |
Kartal, E | 1 |
Mungan, NO | 1 |
Pai, YJ | 1 |
Hutchin, T | 2 |
Brosnan, ME | 1 |
Brosnan, JT | 1 |
Greene, ND | 1 |
Tsurusaki, Y | 1 |
Tanaka, R | 1 |
Shimada, S | 1 |
Shimojima, K | 1 |
Shiina, M | 1 |
Nakashima, M | 1 |
Saitsu, H | 1 |
Miyake, N | 1 |
Ogata, K | 1 |
Yamamoto, T | 1 |
Matsumoto, N | 1 |
Scharer, GH | 2 |
Szerlong, HJ | 1 |
Bjoraker, KJ | 1 |
Mahieu, V | 3 |
Matthijs, G | 2 |
Hennermann, JB | 2 |
Applegarth, DA | 6 |
Toone, JR | 6 |
Williams, K | 1 |
Van Hove, JL | 4 |
Acquaviva, C | 1 |
Väisänen, ML | 1 |
Brás-Goldberg, AM | 1 |
Rahikkala, E | 1 |
Moilanen, JS | 1 |
Bravo-Alonso, I | 2 |
Pérez-Cerdá, C | 2 |
Vianey-Saban, C | 1 |
Contreras-Roura, J | 1 |
Camayd-Viera, I | 1 |
Padrón-Díaz, AD | 1 |
Martínez-Rey, L | 1 |
Alfadhel, M | 1 |
Nashabat, M | 1 |
Qahtani, HA | 1 |
Alfares, A | 1 |
Mutairi, FA | 1 |
Shaalan, HA | 1 |
Douglas, GV | 1 |
Wierenga, K | 1 |
Juusola, J | 1 |
Alrifai, MT | 1 |
Arold, ST | 1 |
Alkuraya, F | 1 |
Ali, QA | 1 |
Kurolap, A | 1 |
Armbruster, A | 1 |
Hershkovitz, T | 1 |
Hauf, K | 1 |
Mory, A | 1 |
Paperna, T | 1 |
Hannappel, E | 1 |
Tal, G | 1 |
Nijem, Y | 1 |
Sella, E | 1 |
Mahajnah, M | 1 |
Ilivitzki, A | 1 |
Hershkovitz, D | 1 |
Ekhilevitch, N | 1 |
Mandel, H | 2 |
Eulenburg, V | 2 |
Baris, HN | 1 |
Moura, AP | 1 |
Parmeggiani, B | 1 |
Gasparotto, J | 1 |
Grings, M | 1 |
Fernandez Cardoso, GM | 1 |
Seminotti, B | 3 |
Moreira, JCF | 1 |
Gelain, DP | 1 |
Wajner, M | 3 |
Leipnitz, G | 3 |
Navarrete, R | 1 |
Perona, A | 1 |
Abia, D | 1 |
Couce, ML | 1 |
Morais, A | 1 |
Domingo, R | 1 |
Ramos, MA | 1 |
Solano, AF | 1 |
Amaral, AU | 2 |
Fernandes, CG | 2 |
Beskow, AP | 1 |
Dutra Filho, CS | 1 |
Manley, BJ | 1 |
Sokol, J | 1 |
Cheong, JL | 1 |
Meyer, S | 1 |
Shamdeen, MG | 1 |
Furtwängler, R | 1 |
Gottschling, S | 1 |
Gortner, L | 1 |
Suzuki, Y | 3 |
Kure, S | 10 |
Oota, M | 1 |
Hino, H | 1 |
Fukuda, M | 1 |
August, DA | 1 |
Nguyen, HG | 1 |
Aburahma, S | 1 |
Khassawneh, M | 1 |
Griebel, M | 1 |
Sharp, G | 1 |
Gibson, J | 1 |
Brunel-Guitton, C | 1 |
Casey, B | 1 |
Coulter-Mackie, M | 1 |
Vallance, H | 1 |
Hewes, D | 1 |
Stockler-Ipsiroglu, S | 1 |
Mercimek-Mahmutoglu, S | 1 |
Knebel, LA | 1 |
da Rosa, MS | 1 |
Eichler, P | 1 |
Viljoen, J | 1 |
Bergh, JJ | 1 |
Mienie, LJ | 1 |
Kotze, HF | 1 |
Terre'Blanche, G | 1 |
Veríssimo, C | 1 |
Garcia, P | 1 |
Simões, M | 1 |
Robalo, C | 1 |
Henriques, R | 1 |
Diogo, L | 1 |
Grazina, M | 1 |
Madu, AE | 1 |
Oliver, L | 1 |
Viola, A | 1 |
Chabrol, B | 1 |
Nicoli, F | 1 |
Confort-Gouny, S | 1 |
Viout, P | 1 |
Cozzone, PJ | 1 |
Korman, SH | 4 |
Gutman, A | 2 |
Paupe, A | 1 |
Bidat, L | 1 |
Sonigo, P | 1 |
Lenclen, R | 1 |
Molho, M | 1 |
Ville, Y | 1 |
Levy, HL | 2 |
Coulter-Mackie, MB | 3 |
Lee, G | 1 |
Chien, YH | 1 |
Hsu, CC | 1 |
Huang, A | 1 |
Chou, SP | 1 |
Lu, FL | 1 |
Lee, WT | 1 |
Hwu, WL | 1 |
Boneh, A | 2 |
Ichinohe, A | 1 |
Kojima, K | 3 |
Ergaz, Z | 1 |
Gomori, JM | 1 |
Hoover-Fong, JE | 1 |
Shah, S | 1 |
Applegarth, D | 1 |
Toone, J | 1 |
Hamosh, A | 1 |
Atay, E | 1 |
Bozaykut, A | 1 |
Sezer, G | 1 |
Flusser, H | 1 |
Matsubara, Y | 5 |
Galil, A | 1 |
Kanno, J | 1 |
Lerer, I | 1 |
Ben-Neriah, Z | 1 |
Okamura-Ikeda, K | 1 |
Hosaka, H | 1 |
Yoshimura, M | 1 |
Yamashita, E | 1 |
Toma, S | 1 |
Nakagawa, A | 1 |
Fujiwara, K | 1 |
Motokawa, Y | 1 |
Taniguchi, H | 1 |
Kaźmierczuk-Skubis, ME | 1 |
Zatorska-Karpuś, M | 1 |
Pac-Kozuchowska, E | 1 |
Bojko-Jaworska, J | 1 |
Furmaga-Jabłońska, W | 1 |
Vande Kerckhove, K | 1 |
Declercq, P | 1 |
Mertens, S | 1 |
De Becker, M | 1 |
Kishnani, PS | 1 |
Jaeken, J | 2 |
Conter, C | 1 |
Rolland, MO | 2 |
Cheillan, D | 1 |
Bonnet, V | 1 |
Maire, I | 1 |
Froissart, R | 1 |
Gomeza, J | 1 |
Armsen, W | 1 |
Betz, H | 1 |
Liu, CM | 1 |
Fan, SZ | 1 |
Tan, ES | 1 |
Wiley, V | 1 |
Carpenter, K | 2 |
Wilcken, B | 2 |
Chiong, MA | 1 |
Procopis, P | 1 |
Bhamkar, RP | 1 |
Colaco, P | 1 |
Lang, TF | 1 |
Parr, JR | 1 |
Matthews, EE | 1 |
Gray, RG | 1 |
Bonham, JR | 1 |
Kay, JD | 1 |
Leisti, J | 1 |
Sakata, Y | 3 |
Tada, K | 1 |
Narisawa, K | 2 |
Jackson, AH | 1 |
van der Knaap, MS | 1 |
Wevers, RA | 1 |
Gabreëls, FJ | 1 |
Verhoeven, NM | 1 |
van Raaij-Selten, B | 1 |
Maeda, T | 1 |
Inutsuka, M | 1 |
Goto, K | 1 |
Izumi, T | 1 |
James, ER | 2 |
Gabis, L | 1 |
Parton, P | 1 |
Roche, P | 1 |
Lenn, N | 1 |
Tudorica, A | 1 |
Huang, W | 1 |
Kudo, T | 1 |
Kanno, K | 1 |
Aoki, Y | 2 |
Shinka, T | 2 |
Owada, Y | 1 |
Hisanaga, K | 1 |
Satoh, J | 1 |
Kondo, H | 1 |
Huisman, TA | 1 |
Thiel, T | 1 |
Steinmann, B | 1 |
Zeilinger, G | 1 |
Martin, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Glycine Transport Inhibition on Brain Glycine Concentration[NCT00538070] | 68 participants (Actual) | Interventional | 2007-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for glycine and Glycine Encephalopathy
Article | Year |
---|---|
[Amplitude-integrated electroencephalography in non-ketotic hyperglycinaemia].
Topics: Carnitine; Consanguinity; Dextromethorphan; Drug Therapy, Combination; Early Diagnosis; Electroencep | 2014 |
Two novel laboratory tests facilitating diagnosis of glycine encephalopathy (nonketotic hyperglycinemia).
Topics: Breath Tests; Carbon Radioisotopes; Glycine; Glycine Dehydrogenase (Decarboxylating); Humans; Hyperg | 2011 |
Non-ketotic hyperglycinaemia: case report and review of medical literature.
Topics: Adult; Diagnosis, Differential; Fatal Outcome; Female; Gestational Age; Glycine; Hiccup; Humans; Hyp | 2013 |
Lessons from the knocked-out glycine transporters.
Topics: Animals; Brain; Disease Models, Animal; Gene Expression Regulation; Glycine; Glycine Plasma Membrane | 2006 |
71 other studies available for glycine and Glycine Encephalopathy
Article | Year |
---|---|
Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia.
Topics: Amino Acids; Cross-Sectional Studies; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; | 2022 |
Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia.
Topics: Glycine; Humans; Hyperglycinemia, Nonketotic; Mutation; Phenotype | 2022 |
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined nonketotic hyperglycinemia and lipoate deficiency.
Topics: Exons; Glycine; Humans; Hyperglycinemia, Nonketotic; Mutation; Proteins | 2023 |
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant | 2022 |
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant | 2022 |
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant | 2022 |
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant | 2022 |
Nonketotic Hyperglycinemia: Two Case Reports and Review.
Topics: Agenesis of Corpus Callosum; Apnea; Brain; Brain Diseases; Electroencephalography; Fatal Outcome; Fe | 2019 |
Non-ketotic hyperglycinaemia: a frequent, but poorly diagnosed and managed genetic disorder in Tunisia.
Topics: Apnea; Chromatography, Ion Exchange; Coma; Consanguinity; Glycine; Humans; Hyperglycinemia, Nonketot | 2021 |
Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non-ketotic hyperglycinemia.
Topics: Alleles; Animals; Brain; Glycine; Glycine Dehydrogenase (Decarboxylating); Hyperglycinemia, Nonketot | 2020 |
Seventeen-year long-term survival of a case of neonatal nonketotic hyperglycinemia.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Glycine; Humans; Hyperglycinemia, Nonketotic; Infa | 2020 |
Nonketotic Hyperglycinemia in Tunisia. Report upon a Series of 69 Patients.
Topics: Age of Onset; Child, Preschool; Consanguinity; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; | 2020 |
GLYT1 encephalopathy: Further delineation of disease phenotype and discussion of pathophysiological mechanisms.
Topics: Abortion, Spontaneous; Arthrogryposis; Female; Genetic Predisposition to Disease; Glycine; Glycine P | 2021 |
Genomic analyses of glycine decarboxylase neurogenic mutations yield a large-scale prediction model for prenatal disease.
Topics: Animals; Disease Models, Animal; Female; Genomics; Genotype; Glycine; Glycine Dehydrogenase (Decarbo | 2021 |
Elevated preoptic brain activity in zebrafish glial glycine transporter mutants is linked to lethargy-like behaviors and delayed emergence from anesthesia.
Topics: Aminobenzoates; Anesthesia, General; Anesthetics; Animals; Animals, Genetically Modified; Craniotomy | 2021 |
Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia.
Topics: Agenesis of Corpus Callosum; Amino Acid Oxidoreductases; Female; Genotype; Glycine; Humans; Hypergly | 2021 |
Biallelic start loss variant, c.1A > G in GCSH is associated with variant nonketotic hyperglycinemia.
Topics: Child, Preschool; Female; Glycine; Glycine Decarboxylase Complex H-Protein; Humans; Hyperglycinemia, | 2021 |
X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid.
Topics: Biomarkers; Brain; Diagnosis, Differential; Genetic Diseases, X-Linked; Glycine; Humans; Hyperglycin | 2017 |
d-Glyceric aciduria does not cause nonketotic hyperglycinemia: A historic co-occurrence.
Topics: Amino Acid Oxidoreductases; Aminomethyltransferase; Carrier Proteins; Diagnosis, Differential; Epile | 2017 |
A novel compound heterozygous variant identified in GLDC gene in a Chinese family with non-ketotic hyperglycinemia.
Topics: Amino Acid Sequence; Asian People; China; Exons; Female; Genetic Variation; Genotype; Glycine; Glyci | 2018 |
Why does hyperglycinemia exhibit so grave brain anomalies and so severe neurological symptoms?
Topics: Brain; Cell Proliferation; DNA; Glycine; Humans; Hyperglycinemia, Nonketotic; Models, Neurological; | 2018 |
Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level.
Topics: Animals; Brain; CRISPR-Associated Protein 9; Dextromethorphan; Excitatory Amino Acid Antagonists; Fa | 2018 |
The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).
Topics: Animals; Chlorocebus aethiops; Dextromethorphan; Glycine; Hyperglycinemia, Nonketotic; Sodium Benzoa | 2019 |
Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing.
Topics: Base Sequence; DNA Mutational Analysis; Female; Genes, Recessive; Glycine; Glycine Dehydrogenase (De | 2014 |
Two novel missense mutations in nonketotic hyperglycinemia.
Topics: Aminomethyltransferase; Epilepsies, Myoclonic; Female; Genetic Predisposition to Disease; Glycine; G | 2015 |
Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice.
Topics: Animals; Base Sequence; DNA Primers; Folic Acid; Formates; Galactosides; Gas Chromatography-Mass Spe | 2015 |
Novel compound heterozygous LIAS mutations cause glycine encephalopathy.
Topics: Adult; Exome; Female; Glycine; Heterozygote; Humans; Hyperglycinemia, Nonketotic; Mutation | 2015 |
Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.
Topics: Animals; Chlorocebus aethiops; COS Cells; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Infa | 2015 |
The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT.
Topics: Alleles; Aminomethyltransferase; Dihydrolipoamide Dehydrogenase; Exons; Female; Genetic Testing; Gen | 2017 |
Biochemical diagnosis of nonketotic hyperglycinemia in Cuba.
Topics: Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant; Infant, Newborn; Male | 2018 |
Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans.
Topics: Amino Acid Oxidoreductases; Animals; Base Sequence; Carrier Proteins; Exome; Female; Glycine; Glycin | 2016 |
Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.
Topics: Animals; Arthrogryposis; Child, Preschool; Female; Gene Deletion; Gene Expression Regulation; Glycin | 2016 |
Glycine Administration Alters MAPK Signaling Pathways and Causes Neuronal Damage in Rat Brain: Putative Mechanisms Involved in the Neurological Dysfunction in Nonketotic Hyperglycinemia.
Topics: Animals; Brain; Corpus Striatum; Dizocilpine Maleate; Glial Fibrillary Acidic Protein; Glycine; Hype | 2018 |
Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease.
Topics: Exons; Gene Expression Regulation, Enzymologic; Glycine; Glycine Dehydrogenase (Decarboxylating); Hu | 2017 |
Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats.
Topics: Animals; Antioxidants; Cerebral Cortex; Cytoprotection; Dose-Response Relationship, Drug; Glutathion | 2009 |
Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia.
Topics: Brain; Cerebral Hemorrhage; Female; Glycine; Hiccup; Humans; Hyperglycinemia, Nonketotic; Infant, Ne | 2010 |
A floppy neonate with respiratory failure and burst suppression EEG (case presentation).
Topics: Diagnosis, Differential; Electroencephalography; Female; Glycine; Humans; Hyperglycinemia, Nonketoti | 2010 |
Nonketotic hyperglycinemia: proposal of a diagnostic and treatment strategy.
Topics: Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; Male | 2010 |
Nitrous oxide for glycine encephalopathy.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Electroencephalography; Gastrostomy; Glycine; Human | 2010 |
Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy.
Topics: Child, Preschool; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Hypoxia, Brain; Infant; Magn | 2011 |
Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene.
Topics: Base Sequence; Child; Dextromethorphan; Excitatory Amino Acid Antagonists; Glycine; Glycine Dehydrog | 2011 |
Glycine intrastriatal administration induces lipid and protein oxidative damage and alters the enzymatic antioxidant defenses in rat brain.
Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Glycine; Glycine Agent | 2011 |
Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Chlorocebus aethiops; Disease Mod | 2012 |
Nonketotic hyperglycinemia: a cause of encephalopathy in children.
Topics: Child; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Intellectual Disability; Lennox Gastaut | 2013 |
Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
Topics: Aspartic Acid; Brain; Child, Preschool; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; | 2002 |
Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia).
Topics: Anticonvulsants; Brain Diseases, Metabolic, Inborn; Child, Preschool; Chromosome Aberrations; Consan | 2002 |
Prenatal diagnosis of hypoplasia of the corpus callosum in association with non-ketotic hyperglycinemia.
Topics: Abnormalities, Multiple; Agenesis of Corpus Callosum; Amino Acid Metabolism, Inborn Errors; Electroe | 2002 |
Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH).
Topics: Aminomethyltransferase; Base Sequence; Glycine; Herpesvirus 4, Human; Humans; Hydroxymethyl and Form | 2003 |
Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
Topics: Brain; Child, Preschool; Chromosome Aberrations; Dextromethorphan; Diazepam; Disease Progression; Di | 2004 |
Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.
Topics: Adult; Amino Acid Oxidoreductases; Child, Preschool; DNA Mutational Analysis; Excitatory Amino Acid | 2004 |
Natural history of nonketotic hyperglycinemia in 65 patients.
Topics: Adolescent; Age of Onset; Agenesis of Corpus Callosum; Anticonvulsants; Apnea; Child; Child, Prescho | 2004 |
Four cases of neonatal non-ketotic hyperglycinaemia.
Topics: Biomarkers; Fatal Outcome; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; Male | 2004 |
Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation.
Topics: Adolescent; Alternative Splicing; Arabs; Brain; Brain Chemistry; Child; Child, Preschool; Disease Pr | 2005 |
A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem.
Topics: Amino Acid Oxidoreductases; Amino Acid Substitution; Arabs; Codon, Initiator; Female; Glycine; Glyci | 2005 |
Crystal structure of human T-protein of glycine cleavage system at 2.0 A resolution and its implication for understanding non-ketotic hyperglycinemia.
Topics: Amino Acid Sequence; Aminomethyltransferase; Animals; Arginine; Asparagine; Binding Sites; Catalytic | 2005 |
Non-ketotic hyperglycinemia as the cause of infant seizures--the case study.
Topics: Brain; Diagnosis, Differential; Electroencephalography; Female; Follow-Up Studies; Glycine; Humans; | 2004 |
Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
Topics: Adolescent; Age Factors; Age of Onset; Amino Acid Oxidoreductases; Anti-Infective Agents; Benzoates; | 2005 |
Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations.
Topics: Aminomethyltransferase; Glycine; Glycine Dehydrogenase (Decarboxylating); Humans; Hyperglycinemia, N | 2006 |
Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy.
Topics: Alleles; Chromatography, High Pressure Liquid; DNA Mutational Analysis; DNA Primers; Female; Gene De | 2006 |
Glycine encephalopathy and delayed emergence from anesthesia.
Topics: Anesthesia; Child, Preschool; Female; Glycine; Humans; Hyperglycinemia, Nonketotic | 2006 |
Non-ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening.
Topics: Glycine; Humans; Hyperglycinemia, Nonketotic; Infant; Infant, Newborn; Neonatal Screening; Tandem Ma | 2007 |
Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course.
Topics: Age of Onset; Brain Diseases, Metabolic; Cerebral Palsy; Child, Preschool; Female; Gait; Glycine; Hu | 2007 |
Neonatal nonketotic hyperglycinemia.
Topics: Amino Acid Metabolism, Inborn Errors; Disease Progression; Fatal Outcome; Glycine; Humans; Hyperglyc | 2007 |
Practical difficulties in the diagnosis of transient non-ketotic hyperglycinaemia.
Topics: Amino Acids; Diagnosis, Differential; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, | 2008 |
Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations.
Topics: Amino Acid Oxidoreductases; Arabs; Carrier Proteins; Case-Control Studies; Chorionic Villi Sampling; | 1999 |
Atypical nonketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio.
Topics: Adolescent; Child; Epilepsy, Complex Partial; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; | 1999 |
Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter.
Topics: Adolescent; Adult; Biomarkers; Brain; Brain Diseases; Child; Child, Preschool; Excitatory Amino Acid | 1999 |
Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures.
Topics: Asphyxia Neonatorum; Brain; Electroencephalography; Glycine; Humans; Hyperglycinemia, Nonketotic; In | 2000 |
Biochemical and molecular investigations of patients with nonketotic hyperglycinemia.
Topics: Amino Acid Sequence; DNA Mutational Analysis; DNA Primers; Exons; Female; Glycine; Homocysteine S-Me | 2000 |
Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH).
Topics: Amino Acid Oxidoreductases; Aminomethyltransferase; DNA Primers; Exons; Gene Frequency; Glycine; Gly | 2001 |
In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia.
Topics: Aspartic Acid; Brain; Brain Diseases, Metabolic; Choline; Chromosome Aberrations; Chromosome Disorde | 2001 |
Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia.
Topics: Alleles; Amino Acid Oxidoreductases; Base Sequence; Chromosome Mapping; Chromosomes, Human, Pair 16; | 2001 |
Structure and expression of the glycine cleavage system in rat central nervous system.
Topics: Age Factors; Amino Acid Oxidoreductases; Amino Acid Sequence; Animals; Astrocytes; Base Sequence; Br | 2001 |
Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation.
Topics: Brain; Brain Chemistry; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; Magnetic Reso | 2002 |